Abstract
Introduction: Assessment of diffuse myocardial fibrosis is possible by cardiovascular magnetic resonance imaging with the quantification of extracellular volume fraction (ECV-CMR). ECV can also be determined by computed tomography angiography (ECV-CTA), using pre- and post-contrast images that are easily incorporated into the standard pre-procedural CTA for planning transcatheter aortic valve replacement (TAVR). There is limited data comparing ECV-CTA to ECV-CMR in this population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
